Myofibrillar Myopathies and Other Myopathies with Rimmed Vacuoles


Introduction

A vacuole is a membrane-bound area of a muscle fibre that may contain various cellular components or enzymes. The type and function of a vacuole vary, and the properties of a vacuole can be a useful pathological indicator. The membrane may be revealed with antibodies to sarcolemmal proteins, or may only be visible with electron microscopy. The nature of the contents of a vacuole may also only be seen with electron microscopy, although some stains (e.g. PAS and acid phosphatase) and some antibodies (e.g. to markers of autophagy or proteins related to ubiquitinylation) can give an indication of the material within a vacuole. It is important to distinguish vacuoles from unstained areas in histologically stained sections (e.g. with haematoxylin and eosin (H&E) and Gomori trichrome), which relate to lipid droplets or ice crystal damage. In some muscle biopsies vacuoles may only be a minor feature, whereas in others they are numerous. In the past, the type of vacuole surrounded by basophilic material that stains red with the Gomori trichrome stain (commonly known as rimmed vacuoles), in particular, was thought to be restricted to disorders such as inclusion body myositis, but it is now apparent that this type of vacuole can occur in a wide variety of disorders, including myopathies, muscular dystrophies and neuropathies. They probably relate to common pathological pathways such as misfolding of proteins, the proteasome and autophagic pathways and various chaperone and co-chaperone proteins ( ). In this chapter we discuss disorders in which vacuoles, together with additional pathological features and the clinical phenotype, can be useful diagnostic clues. In particular, we cover the pathology of myofibrillar myopathies and other disorders with an accumulation of proteins, and some distal myopathies, including those described as hereditary inclusion body myopathies. The pathology and associated phenotype of other disorders where vacuoles of various types are a feature are described in other chapters: glycogenoses (see Ch. 17 ), ion channel disorders (see Ch. 20 ), inclusion body myositis (see Ch. 22 ), myosin 2A myopathy (see Ch. 15 ), oculopharyngeal muscular dystrophy (see Ch. 14 ), LGMD2G (TCAP; see Ch. 11 ) and toxic myopathies (see Ch. 23 ).

Myofibrillar Myopathies

Over the years a number of disorders with various types of inclusions have been described, such as spheroid bodies ( ), sarcoplasmic bodies ( ), cytoplasmic bodies ( ) and granulofilamentous material ( ). More recently, it has been appreciated that these disorders share similar histopathological features, in particular accumulation of several proteins, especially desmin. This led to the use of terms such as ‘desminopathies’, ‘desmin-related myopathies’ and ‘protein aggregate myopathies’ ( ). Several other proteins in addition to desmin also accumulate, several of which are also seen in inclusion body myositis (see Ch. 22 ) and neurodegenerative disorders. The terms ‘hereditary inclusion body myopathy’ or ‘protein surplus myopathies’ have also been suggested ( ), as well as the more general term of ‘myofibrillar myopathies’ ( ). The molecular basis of several of these conditions has now been determined. Although it is now known that defects in several proteins associated with the sarcomere can cause a neuromuscular disorder (see Fig. 8.2 ), the term ‘myofibrillar myopathy’ is usually restricted to conditions in which proteins of the Z line, or associated with it, are implicated. These share some similar pathological features, which include deposition of amorphous or granular aggregates consisting of ectopic proteins, such as desmin, αB-crystallin, myotilin, dystrophin and others, presence of rimmed or non-rimmed vacuoles and focal loss of oxidative enzyme activity ( ). The genes and proteins considered in this section are listed in Table 16.1 .

TABLE. 16.1
The Defective Genes and Proteins Known to Cause a Myofibrillar Myopathy
Gene Symbol Protein Inheritance Cardiac Involvement Clinical Features
DES Desmin AD Yes Adult onset; distal > proximal muscle weakness, axial weakness; respiratory failure
DES Desmin AR Yes Infantile or childhood onset; proximal and distal muscle weakness
CRYAB αB-crystallin AD Yes Distal > proximal muscle weakness; cataracts
CRYAB αB-crystallin AR No Infantile onset; axial and abdominal muscle stiffness and weakness; respiratory failure
MYOT Myotilin AD Yes Adult or late onset; distal and proximal muscle weakness
MYOT Myotilin AR Yes Adult onset; proximal weakness of lower extremities
FLNC Filamin C AD Yes Adult onset; distal < proximal muscle weakness
LDB3 LDB3 ( ZASP ) AD Yes Adult or late onset, occasional childhood onset; distal > proximal muscle weakness; sometimes neuropathy
BAG3 BAG3 AD Yes Early onset; severe progression; neuropathy may occur
FHL1 FHL1 XD Yes Broad phenotype; childhood-onset cases with severe progression
TTN Titin (FN3 119 domain) AD No Adult onset; proximal and distal muscle weakness; early respiratory failure (HMERF)
PLEC Plectin AR Yes Infantile/childhood/adult onset of muscle weakness with proximal and distal muscle weakness; skin blistering
ACTA1 Skeletal muscle
α-actin
AD No Onset in infancy; upper > lower limb; contractures
HSPB8 HSPB8 AD No Adult onset; distal > proximal muscle weakness; peripheral motor neuropathy
DNAJB6 DNAJB6 AD No Childhood/adult onset; distal and proximal muscle weakness
DDB3, LIM domain-binding protein 3; ZASP, Z line alternatively spliced PDZ motif-containing protein; BAG3, Bcl-2-associated athanogene 3; FHL1, four and00 a half LIM domains 1 protein; HSPB8, heat-shock 22-kd protein 8; DNAJB6, DNAJ/HSP40 homolog subfamily B member 6; AD, autosomal dominant; AR, autosomal recessive; XD, X-linked dominant; HMERF, hereditary myopathy with early respiratory failure.

Defects in the proteins that are included in this group of disorders were historically desmin, αB-crystallin, myotilin, Z-line alternatively spliced PDZ motif-containing protein (ZASP), filamin C and bcl-2-associated athanogene 3 (BAG3). More recently, the definition has been broadened to include more protein defects ( ). Four-and-a-half-LIM domain 1 protein (FHL1) is often included, although this is not a protein of the Z line but localizes to the myofibrils and sarcolemma ( ) and also titin, skeletal muscle α-actin, heat-shock 22-kd protein 8 (HSPB8) and DNAJ/HSP40 homolog subfamily B member 6 (DNAJB6) and plectin. Plectin is closely associated with desmin and the Z line, and desmin accumulation occurs when there is a mutation in the gene in common with myofibrillar myopathies. Although vacuoles are not a frequent pathological feature of plectinopathy, it may be grouped among the myofibrillar myopathies because of several other important pathological features ( ). Telethonin is also a protein of the Z line and biopsies can have vacuoles but this is discussed with limb-girdle muscular dystrophies (LGMD2G, ; see Ch. 11 ).

Many cases are sporadic, but when inheritance can be determined, the majority of cases show autosomal dominant inheritance, although rare recessive mutations in the genes encoding desmin, αB-crystallin and myotilin have been identified ( ), and disorders associated with FHL1 are X-linked with mainly dominant inheritance. Myopathies caused by mutations in PLEC are inherited in an autosomal recessive manner.

Clinical Features

With identification of the various molecular defects, the spectrum of clinical features associated with myofibrillar myopathies is expanding. Age of onset is variable and can be in childhood, adolescence or adulthood. Although there is a spectrum of presentation, and many identified cases are of adult onset, often late (beyond the fourth decade), particularly in cases with ZASP, myotilin or filamin C defects, cases with defects associated with the desmin gene tend to present earlier than those with ZASP, myotilin or filamin C defects. Other gene defects, such as BAG3 , CRYAB and ACTA1, frequently present in childhood.

Muscle weakness is often slowly progressive but may be rapid in early-onset cases such as those with FHL1 or BAG3 defects. Childhood cases with these mutations can be particularly severe, with rapid progression. Weakness may be proximal or, more frequently, distal, or both, or scapuloperoneal. Weakness may be asymmetrical in some cases with FHL1 defects. Muscle weakness may be accompanied by muscle wasting, stiffness or aching, cramps and sensory symptoms. Facial weakness is uncommon, but dysarthria and swallowing difficulties may occur in some older patients. Wasting of hand muscles occurs in cases with mutations in the actin-binding domain of filamin C but the cases reported do not show the typical pathology of myofibrillar myopathies: in particular, no vacuoles ( ). Evidence of peripheral neuropathy is present in a significant proportion of patients, particularly in cases with BAG3 and HSPB8 mutations, and some show myotonic discharges. Cardiac involvement is common, particularly in those with a mutation in the gene encoding desmin, when it may precede or coincide with skeletal muscle weakness. Cardiac involvement may be in the form of arrhythmia, or dilated or hypertrophic cardiomyopathy. Cardiomyopathy is a feature of BAG3 cases with childhood onset and occurs in cases with mutations affecting filamin C and FHL1 but is more rare in those with defects in myotilin. Respiratory failure is present in several cases of myofibrillar myopathies, especially those that present early, and is a common feature of hereditary myopathy with early respiratory failure (HMERF) associated with mutations in the gene encoding titin. Cataracts are a feature associated with mutations in the αB-crystallin gene and can be a useful clinical distinction from other forms of myofibrillar myopathy, although they may not be detected in cases presenting early ( ). Other features that can occur are rigid spine, scoliosis and contractures, and scapular winging is common ( ). When defects in the gene encoding myotilin were first identified the disorder was described as limb-girdle muscular dystrophy 1A but it is now appreciated that this is the same disorder as that now known as a myofibrillar myopathy ( ).

Serum creatine kinase (CK) activity is either normal or mildly elevated, but some cases, such as BAG3- or myotilin-related cases, may have a pronounced increase. Muscle magnetic resonance imaging (MRI) patterns, in conjunction with clinicopathological studies, can be helpful in distinguishing the subtype of myofibrillar myopathy ( ), but there is also overlap between them, and the stage of disease has to be taken into account.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here